Diabetic painful neuropathy: Current and future treatment options

Drugs

Volumn 67, Issue 4, 2007, Pages 569-585

  Chong, M Sam ^a,b   Hester, Joan ^b  

^a MEDWAY MARITIME HOSPITAL   (United Kingdom)

^b KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSE REDUCTASE INHIBITOR; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTILIPEMIC AGENT; ARSENIC; CAPSAICIN; CISPLATIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DULOXETINE; GABAPENTIN; HARKOSERIDE; ISONIAZID; LAMOTRIGINE; LIDOCAINE; LOCAL ANESTHETIC AGENT; OPIATE; OXCARBAZEPINE; OXYCODONE; PREGABALIN; SEROTONIN UPTAKE INHIBITOR; TETRACYCLIC ANTIDEPRESSANT AGENT; THALLIUM; THIOCTIC ACID; TOPIRAMATE; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE; VINCRISTINE;

ADDICTION; ALCOHOLISM; ALLODYNIA; BLOOD GLUCOSE MONITORING; CARDIOTOXICITY; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONSTIPATION; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC NEUROPATHY; DISEASE SEVERITY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG TOLERABILITY; FOOT ULCER; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; METABOLIC DISORDER; NEUROPATHIC PAIN; PANCREAS SURGERY; PARANEOPLASTIC SYNDROME; PHYSICAL EXAMINATION; REVIEW; RISK FACTOR; SYMPTOM; TRANSCUTANEOUS NERVE STIMULATION; VASCULITIS; VITAMIN DEFICIENCY;

ANALGESICS, OPIOID; ANTICONVULSANTS; CAPSAICIN; CONTROLLED CLINICAL TRIALS; DIABETES MELLITUS; DIABETIC NEUROPATHIES; HUMANS; HYPOGLYCEMIC AGENTS; PAIN; SEROTONIN UPTAKE INHIBITORS;

EID: 33947310739     PISSN: 00126667     EISSN: 00126667     Source Type: Journal    
DOI: 10.2165/00003495-200767040-00006     Document Type: Review

References (91)

1. Boru UT, Alp R, Sargin H, et al. Prevalence of peripheral neuropathy in type 2 diabetic patients attending a diabetes center in Turkey. Endocr J 2004 Dec; 51 (6): 563-7
2. Daousi C, MacFarlane IA, Woodward A, et al. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diabet Med 2004 Sep; 21 (9): 976-82
3. Novella SP, Inzucchi SE, Goldstein JM. The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy. Muscle Nerve 2001 Sep; 24 (9): 1229-31
4. Singleton JR, Smith AG, Bromberg MB. Painful sensory polyneuropathy associated with impaired glucose tolerance. Muscle Nerve 2001 Sep; 24 (9): 1225-8
5. Gooch C, Podwall D. The diabetic neuropathies. Neurologist 2004 Nov; 10 (6): 311-22
6. Merskey H, Bogduk N, editors. IASP: task force on taxonomy. Classification of chronic pain. 2nd ed. Seattle (WA): IASP Press, 1994
7. Cruccu G, Anand P, Attal N, et al. EFNS guidelines on neuropathic pain assessment. Eur J Neurol 2004 Mar; 11 (3): 153-62
8. Bennett M. The LANSS Pain Scale: the Leeds Assessment of Neuropathic Symptoms and Signs. Pain 2001 May; 92 (1-2): 147-57
9. Galer BS, Jensen MP. Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale. Neurology 1997 Feb; 48 (2): 332-8
10. Shy ME, Frohman EM, So YT, et al. Quantitative sensory testing: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2003 Mar 25; 60 (6): 898-904
11. Polydefkis M, Hauer P, Griffin JW, et al. Skin biopsy as a tool to assess distal small fiber innervation in diabetic neuropathy. Diabetes Technol Ther 2001 Spring; 3 (1): 23-8
12. Tesfaye S, Stevens LK, Stephenson JM, et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia 1996 Nov; 39 (11): 1377-84
13. Sorensen L, Molyneaux L, Yue DK. Insensate versus painful diabetic neuropathy: the effects of height, gender, ethnicity and glycaemic control. Diabetes Res Clin Pract 2002 Jul; 57 (1): 45-51
14. Herman WH, Aubert RE, Engelgau MM, et al. Diabetes mellitus in Egypt: glycaemic control and microvascular and neuropathic complications. Diabet Med 1998 Dec; 15 (12): 1045-51
15. Oyibo SO, Prasad YD, Jackson NJ, et al. The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study. Diabet Med 2002 Oct; 19 (10): 870-3
16. Oates PJ. Polyol pathway and diabetic peripheral neuropathy. Int Rev Neurobiol 2002; 50: 325-92
17. Hotta N, Toyota T, Matsuoka K, et al. Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study. Diabetes Care 2001 Oct; 24 (10): 1776-82
18. Hotta N, Sakamoto N, Shigeta Y, et al. Clinical investigation of epalrestat, an aldose reductase inhibitor, on diabetic neuropathy in Japan: multicenter study. Diabetic Neuropathy Study Group in Japan. J Diabetes Complications 1996 May-Jun; 10 (3): 168-72
19. Hotta N, Akanuma Y, Kawamori R, et al. Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial. Diabetes Care 2006 Jul; 29 (7): 1538-44
20. Malik RA, Williamson S, Abbott C, et al. Effect of angiotensin- converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial. Lancet 1998 Dec 19-26; 352 (9145): 1978-81
21. Fried LF, Forrest KY, Ellis D, et al. Lipid modulation in insulin-dependent diabetes mellitus: effect on microvascular outcomes. J Diabetes Complications 2001 May-Jun; 15 (3): 113-9
22. Leiter LA. The prevention of diabetic microvascular complications of diabetes: is there a role for lipid lowering? Diabetes Res Clin Pract 2005 Jun; 68 Suppl. 2: S3-14
23. Ziegler D, Nowak H, Kempler P, et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med 2004 Feb; 21 (2): 114-21
24. Ziegler D, Hanefeld M, Ruhnau KJ, et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group: Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care 1999 Aug; 22 (8): 1296-301
25. Ziegler D, Ametov A, Barinov A, et al. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care 2006 Nov; 29 (11): 2365-70
26. Agudo R, Valls-Sole J, Recasens M, et al. Effects of kidney and pancreas transplantation on neurophysiological rates of poly-neuropathy and autonomous cardiac function in diabetic patients with end-stage renal disease [in Spanish]. Med Clin (Barc) 2002 Apr 20; 118 (14): 534-8
27. Norden G, Olausson M, Andersen O. A case of painful progressive peripheral neuropathy after successful pancreas transplantation. J Diabet Complications 1991 Oct-Dec; 5 (4): 249-51
28. Forst T, Nguyen M, Forst S, et al. Impact of low frequency transcutaneous electrical nerve stimulation on symptomatic diabetic neuropathy using the new Salutaris device. Diabetes Nutr Metab 2004 Jun; 17 (3): 163-8
29. Kumar D, Marshall HJ. Diabetic peripheral neuropathy: amelioration of pain with transcutaneous electrostimulation. Diabetes Care 1997 Nov; 20 (11): 1702-5
30. Daousi C, Benbow SJ, MacFarlane IA. Electrical spinal cord stimulation in the long-term treatment of chronic painful diabetic neuropathy. Diabet Med 2005 Apr; 22 (4): 393-8
31. Khedr EM, Kotb H, Kamel NF, et al. Longlasting antalgic effects of daily sessions of repetitive transcranial magnetic stimulation in central and peripheral neuropathic pain. J Neurol Neurosurg Psychiatry 2005 Jun; 76 (6): 833-8
32. Cohen KL, Harris S. Efficacy and safety of nonsteroidal anti-inflammatory drugs in the therapy of diabetic neuropathy. Arch Intern Med 1987 Aug; 147 (8): 1442-4
33. Harati Y, Gooch C, Swenson M, et al. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 1998 Jun; 50 (6): 1842-6
34. Gimbel JS, Richards P, Portenoy RK. Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial. Neurology 2003 Mar 25; 60 (6): 927-34
35. Rowbotham MC, Goli V, Kunz NR, et al. Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Pain 2004 Aug; 110 (3): 697-706
36. Goldstein DJ, Lu Y, Detke MJ, et al. Duloxetine vs placebo in patients with painful diabetic neuropathy. Pain 2005 Jul; 116 (1-2): 109-18
37. Raskin J, Pritchett YL, Wang F, et al. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med 2005 Sep-Oct; 6 (5): 346-56
38. Wernicke JF, Pritchett YL, D'Souza DN, et al. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology 2006 Oct; 67 (8): 1411-20
39. Backonja M, Beydoun A, Edwards KR, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 1998 Dec 2; 280 (21): 1831-6
40. Kochar DK, Jain N, Agarwal RP, et al. Sodium valproate in the management of painful neuropathy in type 2 diabetes: a randomized placebo controlled study. Acta Neurol Scand 2002; 106: 248-52
41. Eisenberg E, Lurie Y, Braker C, et al. Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study. Neurology 2001 Aug 14; 57 (3): 505-9
42. Dogra S, Beydoun S, Mazzola J, et al. Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study. Eur J Pain 2005 Oct; 9 (5): 543-54
43. Beydoun A, Shaibani A, Hopwood M, et al. Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging study. Acta Neurol Scand 2006 Jun; 113 (6): 395-404
44. Raskin P, Donofrio PD, Rosenthal NR, et al. Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology 2004 Sep 14; 63 (5): 865-73
45. Rosenstock J, Tuchman M, LaMoreaux L, et al. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain 2004 Aug; 110 (3): 628-38
46. Lesser H, Sharma U, LaMoreaux L, et al. Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial. Neurology 2004 Dec 14; 63 (11): 2104-10
47. Richter RW, Portenoy R, Sharma U, et al. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. J Pain 2005 Apr; 6 (4): 253-60
48. Freynhagen R, Strojek K, Griesing T, et al. Efficacy of pre-gabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain 2005 Jun; 115 (3): 254-63
49. The Capsaicin Study Group. Treatment of painful diabetic neuropathy with topical capsaicin: a multicenter, double-blind, vehicle-controlled study. Arch Intern Med 1991 Nov; 151 (11): 2225-9
50. Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. BMJ 1995 Feb 18; 310 (6977): 452-4
51. McQuay HJ, Moore RA. Using numerical results from systematic reviews in clinical practice. Ann Intern Med 1997 May 1; 126 (9): 712-20
52. Moore RA, Gavaghan D, Tramer MR, et al. Size is everything: large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain 1998 Dec; 78 (3): 209-16
53. Farrar JT, Young JP Jr, LaMoreaux L, et al. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001 Nov; 94 (2): 149-58
54. Gourlay GK. Advances in opioid pharmacology. Support Care Cancer 2005 Mar; 13 (3): 153-9
55. Watson CP, Moulin D, Watt-Watson J, et al. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain 2003 Sep; 105 (1-2): 71-8
56. British Pain Society [online]. Available from URL: http:// www.britishpainsociety.org [Accessed 2006 Dec 14]
57. Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 1999 Dec; 83 (3): 389-400
58. Max MB, Lynch SA, Muir J, et al. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992 May 7; 326 (19): 1250-6
59. Kvinesdal B, Molin J, Froland A, et al. Imipramine treatment of painful diabetic neuropathy. JAMA 1984 Apr 6; 251 (13): 1727-30
60. Sindrup SH, Ejlertsen B, Froland A, et al. Imipramine treatment in diabetic neuropathy: relief of subjective symptoms without changes in peripheral and autonomic nerve function. Eur J Clin Pharmacol 1989; 37 (2): 151-3
61. Sindrup SH, Gram LF, Skjold T, et al. Concentration-response relationship in imipramine treatment of diabetic neuropathy symptoms. Clin Pharmacol Ther 1990 Apr; 47 (4): 509-15
62. Sindrup SH, Gram LF, Skjold T, et al. Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms: a double-blind cross-over study. Br J Clin Pharmacol 1990 Nov; 30 (5): 683-91
63. Max MB, Kishore-Kumar R, Schafer SC, et al. Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial. Pain 1991 Apr; 45 (1): 3-9
64. Sindrup SH, Gram LF, Brosen K, et al. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain 1990 Aug; 42 (2): 135-44
65. Sindrup SH, Bjerre U, Dejgaard A, et al. The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. Clin Pharmacol Ther 1992 Nov; 52 (5): 547-52
66. Chadda VS, Mathur MS. Double blind study of the effects of diphenylhydantoin sodium on diabetic neuropathy. J Assoc Physicians India 1978 May; 26 (5): 403-6
67. Saudek CD, Werns S, Reidenberg MM. Phenytoin in the treatment of diabetic symmetrical polyneuropathy. Clin Pharmacol Ther 1977 Aug; 22 (2): 196-9
68. Rull JA, Quibrera R, Gonzalez-Millan H, et al. Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol): double blind crossover trial. Diabetologia 1969 Aug; 5 (4): 215-8
69. Mellegers MA, Furlan AD, Mailis A. Gabapentin for neuropathic pain: systematic review of controlled and uncontrolled literature. Clin J Pain 2001 Dec; 17 (4): 284-95
70. Sindrup SH, Otto M, Bach FW, et al. Sodium valproate in painful diabetic polyneuropathy. Acta Neurol Scand 2003 Dec; 108 (6): 443-4
71. Vinik AI, Tuchman M, Safirstein B, et al. Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double-blind, placebo-controlled studies. Pain. Epub 2006 Dec 8
72. Thienel U, Neto W, Schwabe SK, et al. Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials. Acta Neurol Scand 2004 Oct; 110 (4): 221-31
73. Donofrio PD, Raskin P, Rosenthal NR, et al. Safety and effectiveness of topiramate for the management of painful diabetic peripheral neuropathy in an open-label extension study. Clin Ther 2005 Sep; 27 (9): 1420-31
74. Oaklander AL, Buchbinder BR. Pregabalin-withdrawal encephalopathy and splenial edema: a link to high-altitude illness? Ann Neurol 2005 Aug; 58 (2): 309-12
75. Atli A, Dogra S. Zonisamide in the treatment of painful diabetic neuropathy: a randomized, double-blind, placebo-controlled pilot study. Pain Med 2005 May-Jun; 6 (3): 225-34
76. Ertas M, Sagduyu A, Arac N, et al. Use of levodopa to relieve pain from painful symmetrical diabetic polyneuropathy. Pain 1998 Apr; 75 (2-3): 257-9
77. Yuen KC, Baker NR, Rayman G. Treatment of chronic painful diabetic neuropathy with isosorbide dinitrate spray: a double-blind placebo-controlled cross-over study. Diabetes Care 2002 Oct; 25 (10): 1699-703
78. Devers A, Galer BS. Topical lidocaine patch relieves a variety of neuropathic pain conditions: an open-label study. Clin J Pain 2000 Sep; 16 (3): 205-8
79. Barbano RL, Herrmann DN, Hart-Gouleau S, et al. Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy. Arch Neurol 2004 Jun; 61 (6): 914-8
80. Biesbroeck R, Bril V, Hollander P, et al. A double-blind comparison of topical capsaicin and oral amitriptyline in painful diabetic neuropathy. Adv Ther 1995 Mar-Apr; 12 (2): 111-20
81. Nelson KA, Park KM, Robinovitz E, et al. High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia. Neurology 1997 May; 48 (5): 1212-8
82. Pellegrino RG, Petit WA, Brazg R, et al. Memantine in the treatment of diabetic peripheral neuropathy: a placebo-controlled phase II trial [abstract no. S15.004]. Neurology 2000; 54 (7 Suppl. 3): A82
83. Sang CN, Booher S, Gilron I, et al. Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials. Anesthesiology 2002 May; 96 (5): 1053-61
84. Schwarz Pharma. Positive data from phase III program for lacosamide [online]. Available from URL: http://www. schwarzpharma.com/?.node_id = 2418 [Accessed 2006 Dec 14]
85. ClinicalTrials.gov. Randomised control trial studying the addition of CBME to conventional treatment for the relief of painful diabetic neuropathy [online]. Available from URL: http://www.clinicaltrials.gov/ct/show/NCT00238550 [Accessed 2006 Dec 14]
86. TimesOnline. Cannabis experiment helps kill OAP, says coroner [online]. Available from URL: http://www.timesonline. co.uk/article/0,2-1936405,00.html [Accessed 2006 Dec 14]
87. Finnerup NB, Otto M, McQuay HJ, et al. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 2005 Dec 5; 118 (3): 289-305
88. Morello CM, Leckband SG, Stoner CP, et al. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Intern Med 1999 Sep 13; 159 (16): 1931-7
89. Dallocchio C, Buffa C, Mazzarello P, et al. Gabapentin vs amitriptyline in painful diabetic neuropathy: an open-label pilot study. J Pain Symptom Manage 2000 Oct; 20 (4): 280-5
90. Rasmussen PV, Sindrup SH, Jensen TS, et al. Therapeutic outcome in neuropathic pain: relationship to evidence of nervous system lesion. Eur J Neurol 2004 Aug; 11 (8): 545-53
91. Gilron I, Bailey JM, Tu D, et al. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005 Mar 31; 352 (13): 1324-34